Mariner’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,712
Closed -$152K 3574
2025
Q3
$152K Buy
+10,712
New +$141K ﹤0.01% 3272
2025
Q2
Sell
-23,949
Closed -$357K 3511
2025
Q1
$357K Buy
+23,949
New +$411K ﹤0.01% 2478
2024
Q4
Sell
-10,870
Closed -$146K 3400
2024
Q3
$146K Buy
+10,870
New +$160K ﹤0.01% 3014
2024
Q1
Sell
-125,754
Closed -$2.85M 3147
2023
Q4
$2.85M Sell
125,754
-122
-0.1% -$2.65K 0.01% 906
2023
Q3
$3.12M Buy
125,876
+118,420
+1,588% +$2.98M 0.01% 805
2023
Q2
$209K Buy
+7,456
New +$185K ﹤0.01% 2432
2022
Q4
Sell
-7,399
Closed -$210K 2755
2022
Q3
$210K Buy
+7,399
New +$190K ﹤0.01% 2028
2015
Q4
Sell
-20,000
Closed -$272K 486
2015
Q3
$272K Buy
+20,000
New +$272K 0.01% 421

Other funds holding CCRN

Mariner's CCRN Position: Q4 2025 in Review

Mariner sold out of Cross Country Healthcare (CCRN) in Q4 2025, closing a stake of 10,712 shares — an estimated $152K sold.

Mariner first reported a position in CCRN in Q3 2015 and held it in 8 quarters. The position peaked at $3.12M in Q3 2023. 147 funds tracked by Wall St. Rank hold CCRN as of Q4 2025.

  • Mariner reported no remaining Cross Country Healthcare position as of Q4 2025 after selling out during the quarter.
  • Mariner sold 10,712 Cross Country Healthcare shares in Q4 2025, an estimated $152K.
  • Mariner first reported a position in Cross Country Healthcare in Q3 2015 and held it in 8 quarters.
  • Mariner's Cross Country Healthcare position peaked at $3.12M in Q3 2023.
  • 147 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q4 2025.

Based on Mariner's 13F filing for Q4 2025, filed 13 Feb 2026.